NCT02862145View on ClinicalTrials.gov

Pharmacodynamics Study of MRX34, MicroRNA Liposomal Injection in Melanoma Patients With Biopsy Accessible Lesions

PHASE1/PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 31, 2016

Primary Completion Date

September 30, 2017

Study Completion Date

December 31, 2017

Conditions
Melanoma
Interventions
DRUG

MRX34

Treatment of melanoma with pharmacodynamics biopsy of tissue and blood

DRUG

Dexamethasone

Premedication during the week of treatment

Sponsors
All Listed Sponsors
lead

Mirna Therapeutics, Inc.

INDUSTRY